Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

• Prif Awduron: Anna Maisa (Awdur), Christian Kollan (Awdur), Matthias an der Heiden (Awdur), Florian van Bömmel (Awdur), Markus Cornberg (Awdur), Stefan Mauss (Awdur), Heiner Wedemeyer (Awdur), Daniel Schmidt (Awdur), Sandra Dudareva (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...